Komori
Ishikawa Seisakusho (6208) · InitiativeHigher R&D Expenses

Group-wide research and development activities

First written in FY2017-Q1. 6 of 33 entries say "Restated". Latest entry: FY2026.

33entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017-Q1 – FY20262016: 220162017: 420172018: 320182019: 420192020: 420202021: 420212022: 320222023: 420232024: 220242025: 220252026: 12026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 223 companies write about · 0 as a headwind · 236 as a tailwind

95 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 238 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Higher R&D ExpensesAnnual report

    「The Group conducts research and development of new products to meet users’ increasingly diverse needs. The Group’s total research and development expenses for the fiscal year were ¥399 million.」

    The Group continued its research and development of new products to address increasingly diverse user needs. Total research and development expenses increased from ¥393 million in the previous fiscal year to ¥399 million.
  2. FY2026-H1Higher R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the interim consolidated accounting period were ¥188 million.」

    The Group’s research and development expenses increased from ¥178 million in the same period of the previous year to ¥188 million. The continuation of research and development activities and the increase in total expenses were described.
  3. FY2025Higher R&D ExpensesAnnual report

    「The Group’s total research and development expenses for the fiscal year were ¥393 million.」

    The Group’s research and development expenses increased from ¥317 million in the previous fiscal year to ¥393 million.
  4. FY2025-H1Higher R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the interim consolidated accounting period were ¥178 million.」

    The Group’s research and development expenses increased from ¥157 million in the same period of the previous year to ¥178 million. The continuation of research and development activities and the increase in total expenses were described.
  5. FY2024-Q3Decrease in R&D ExpensesAnnual report

    「Total R&D expenses for the Group as a whole during the first nine months of the current consolidated fiscal year were ¥214 million.」

    The Group continued its research and development activities, but research and development expenses decreased from ¥242 million in the same period of the previous year to ¥214 million.
  6. FY2024-Q2Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative second-quarter period were ¥124 million.」

    The Group continued its research and development activities, but research and development expenses decreased from ¥157 million in the same period of the previous year to ¥124 million.
  7. FY2024-Q1Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative first-quarter period were ¥61 million.」

    The Group continued its research and development activities, but research and development expenses decreased from ¥78 million in the same period of the previous year to ¥61 million.
  8. FY2023Decrease in R&D ExpensesAnnual report

    「The Group’s total research and development expenses for the fiscal year were ¥317 million.」

    The Group continued its research and development of new products, but total research and development expenses decreased from ¥335 million in the previous fiscal year to ¥317 million.
  9. FY2023-Q3Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative third-quarter period were ¥242 million.」

    The Group continued its research and development activities. Research and development expenses increased from ¥224 million in the same period of the previous year to ¥242 million.
  10. FY2023-Q2Higher R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative second-quarter period were ¥157 million.」

    The Group’s research and development expenses increased from ¥155.843 million in the same period of the previous year to ¥157 million. Its research and development activities continued.
  11. FY2023-Q1Higher R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative first-quarter period were ¥78 million.」

    The Group continued its research and development activities, and research and development expenses increased from ¥69.973 million in the same period of the previous year to ¥78 million.
  12. FY2022-Q3Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative third-quarter period were ¥224 million.」

    The Group continued its research and development activities, but total research and development expenses decreased from ¥251.966 million in the same period of the previous year to ¥224 million.
  13. FY2022-Q2Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative second-quarter period were ¥142 million.」

    The Group continued its research and development activities, but research and development expenses decreased from ¥155.843 million in the same period of the previous year to ¥142 million.
  14. FY2022-Q1Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative first-quarter period were ¥69.973 million.」

    The Group continued its research and development activities, but total research and development expenses decreased from ¥72.209 million in the same period of the previous year to ¥69.973 million.
  15. FY2021Decrease in R&D ExpensesAnnual report

    「The Group’s total research and development expenses for the fiscal year were ¥335 million.」

    The Group continued its research and development of new products, but total research and development expenses decreased from ¥341.041 million in the previous fiscal year to ¥335.673 million.
  16. FY2021-Q3Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative third-quarter period were ¥248.366 million.」

    The Group continued its research and development activities, but total research and development expenses decreased from ¥251.966 million in the same period of the previous year to ¥248.366 million.
  17. FY2021-Q2Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative second-quarter period were ¥155.843 million.」

    The Group continued its research and development activities, but total research and development expenses decreased from ¥158.515 million in the same period of the previous year to ¥155.843 million.
  18. FY2021-Q1Higher R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative first-quarter period were ¥73.743 million.」

    The Group continued its research and development activities. Total research and development expenses increased from ¥72.209 million in the same period of the previous year to ¥73.743 million.
  19. FY2020Higher R&D ExpensesAnnual report

    「The Group conducts research and development of new products to meet users’ increasingly diverse needs. The Group’s total research and development expenses for the fiscal year were ¥341.041 million.」

    The Group continued its research and development of new products, and total research and development expenses increased from ¥324.428 million in the previous fiscal year to ¥341.041 million.
  20. FY2020-Q3Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative third-quarter period were ¥251.966 million.」

    The Group continued its research and development activities, but total research and development expenses decreased from ¥254.818 million in the same period of the previous year to ¥251.966 million.
  21. FY2020-Q2Higher R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative second-quarter period were ¥158.515 million.」

    The Group’s total research and development expenses reached ¥158.515 million, up from ¥146.354 million in the same period of the previous year. The continuation of research and development activities was confirmed, but no specific achievements involving new products or other items were described.
  22. FY2020-Q1Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative first-quarter period were ¥72.209 million.」

    The Group continued its research and development activities, but research and development expenses decreased from ¥89.417 million in the same period of the previous year to ¥72.209 million.
  23. FY2019Decrease in R&D ExpensesAnnual report

    「The Group conducts research and development of new products to meet users’ increasingly diverse needs. The Group’s total research and development expenses for the fiscal year were ¥324.428 million.」

    The Group continued its research and development of new products, but total research and development expenses decreased from ¥359.581 million in the previous fiscal year to ¥324.428 million.
  24. FY2019-Q3Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative third-quarter period were ¥227.504 million.」

    The Group continued its research and development activities, but total research and development expenses decreased from ¥254.818 million in the same period of the previous year to ¥227.504 million.
  25. FY2019-Q2Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative second-quarter period were ¥146.354 million.」

    The Group continued its research and development activities, but total research and development expenses decreased from ¥164.652 million in the same period of the previous year to ¥146.354 million.
  26. FY2019-Q1Decrease in R&D ExpensesAnnual report

    「The total research and development expenses for the Group during the cumulative first-quarter period were ¥68.054 million.」

    The Group continued its research and development activities, but total research and development expenses decreased from ¥89.417 million in the same period of the previous year to ¥68.054 million.
  27. FY2018-Q3RestatedAnnual report

    「The total research and development expenses for the Group during the cumulative third-quarter period were ¥254.818 million.」

    Disclosure of the Group’s research and development activities and cumulative research and development expenses continued. Total research and development expenses reached ¥254.818 million.
  28. FY2018-Q2RestatedAnnual report

    「The total research and development expenses for the Group during the cumulative second-quarter period were ¥164.652 million.」

    The Group continued its research and development activities and disclosed total research and development expenses of ¥164.652 million for the cumulative second-quarter period.
  29. FY2018-Q1RestatedAnnual report

    「The total research and development expenses for the Group during the cumulative first-quarter period were ¥89.417 million.」

    The Group continued its research and development activities, and total research and development expenses for the cumulative first-quarter period were ¥89.417 million.
  30. FY2017RestatedAnnual report

    「The Group conducts research and development of new products to meet users’ increasingly diverse needs. The Group’s total research and development expenses for the fiscal year were ¥384.311 million.」

    The policy of conducting research and development of new products across the Group to address increasingly diverse user needs, and the disclosure of annual research and development expenses of ¥384.311 million, continued.
  31. FY2017-Q3RestatedAnnual report

    「The total research and development expenses for the Group during the cumulative third-quarter period were ¥299.479 million.」

    Disclosure of the Group’s research and development activities and cumulative research and development expenses continued. Total research and development expenses reached ¥299.479 million.
  32. FY2017-Q2RestatedAnnual report

    「The total research and development expenses for the Group during the cumulative second-quarter period were ¥195.308 million.」

    Disclosure of the Group’s research and development activities and cumulative expenses continued, with total research and development expenses reaching ¥195.308 million.
  33. FY2017-Q1First statedAnnual report

    「The total research and development expenses for the Group during the cumulative first-quarter period were ¥95.324 million.」

    The Group recorded ¥95.324 million in research and development expenses during the quarter. This is a disclosure of the total amount across the existing research and development descriptions for paper-processing machinery and defense equipment.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Ishikawa Seisakusho's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.